On-Demand Webinars

  1. Next-Gen analytics for mRNA and LNPs: when traditional methods fall short 11/14/2025
  2. Integrated Manufacturing To Mitigate CMC Risks, Simplify Commercial Supply 10/15/2025

    Leveraging cross-functional coordination between sites, harmonized tech transfers, one quality system, and synchronized team activities can streamline regulatory submissions and deliver high-quality commercial outcomes.

  3. From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined 10/14/2025

    Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.

  4. TARGATT™ Rapid And Efficient Transgene Integration Technology: Stable Cell Line Development And Generation Of Large Mammalian Cell-Based Screening Libraries 10/3/2025

    TARGATT™ technology enables precise, efficient single-copy gene integration into safe harbor loci for stable cell line generation and large-scale mammalian cell library screening.

  5. Advancing Therapeutic Development With iPSC, Genome Editing Tech 10/3/2025

    Genome editing and iPSC technologies can speed up preclinical model creation, assay development, safety testing, and CMC consultation to streamline screenings and IND filing.

  6. How-To Guide For TARGATT™ Transgenic Kit 10/3/2025

    The TARGATT™ Kit enables fast, precise site-specific transgenic mice generation, avoiding random insertion issues and ensuring stable gene expression within three months.

  7. iPSC Genome Editing Rapid Automated Cell Line Editing (RACE™) 10/3/2025

    Expert genome editing and iPSC services support preclinical development, offering cell line creation, assays, safety assessments, and manufacturing consultation to accelerate IND-filing readiness.

  8. Humanized M-NSG PBMC And CD34+ Mouse Models 2023 10/3/2025

    Humanized M-NSG mouse models reconstructed with human PBMCs or CD34+ stem cells offer reliable, ready-to-use tools for infectious disease and immunology research.

  9. Human iPSC Modeling, Drug Screening For Neurodegenerative Disorders 10/3/2025

    iPSC technology enables genetically engineered human cells for neurotoxicity and neuroprotection assays, offering scalable disease models for drug discovery and toxicity screening.

  10. Autobioluminescent Cells For Reduced Optical Imaging Cost, Complexity 10/3/2025

    Autobioluminescent cells autonomously produce continuous bioluminescent signals without added substrates, enabling cost-effective, non-destructive imaging and improved data collection workflows.